Taraxer-14-en-3β-ol, an Anti-Inflammatory Compound from Sterculia foetida L.

Abstract

Taraxer-14-en-3β-ol (1) was shown to be the active ingredient in the leaves of Sterculia foetida L. The alcohol 1, its acetate and ketone showed anti-inflammatory activity against TPA induced mouse ear oedema with inhibition ratios of 60.0, 58.57 and 40.57 at 0.5 mg/ear, respectively. The percentage inhibition of inflammation increased with dose for each compound.

References

• 1 Mujumdar A M, Naik D G, Waghole R J, Kulkarni D K, Kumbhojkar M S. Pharmacological studies on Sterculia foetida leaves.  Pharm Biol. 2000;  38 13-7
• 2 Young J M, De Young L M. Pharmacological methods in the control of inflammation. In: Spector J, Back N, editors New York; Alan R. Liss, Inc 1989: pp 215-31
• 3 Brooks C JW. Observations on taraxerol (skimmiol). J Chem Soc 1955: 1674-7
• 4 Paul B D, Rao G S. Kapadia GJ. Isolation of myricadiol, myricitrin, taraxerol and taraxerone from Myrica cerifera L. root bark.  J Pharmaceutical Sci. 1974;  63 958-9
• 5 Bates R B, Jacobsen N E, Setzer W N, Stessman C C. NMR assignments and conformation of taraxerenes.  Magnetic Resonance in Chemistry. 1998;  36 539-41
• 6 De Young L, Kheifts J, Young J. Edema and cell in filtration in the phorbol treated mouse ear are temporally separate and can be differentially modulated by pharmacological agents.  Agents and Actions. 1989;  26 335-41